Scientists have created a groundbreaking solution in the form of contact lenses equipped with tiny sensors. These sensors gauge the pressure within the eye and relay this crucial information to an eye specialist for analysis. The primary goal is to facilitate the early detection of glaucoma, a condition that, if untreated, can result in irreversible vision impairment.
Glaucoma arises when the optic nerve, linking the eye to the brain, sustains damage due to elevated intraocular pressure (IOP), often caused by fluid accumulation in the eye's front part. If left unattended, glaucoma has the potential to cause irreversible vision loss. One of the challenges is that it's sometimes referred to as the 'silent thief of sight' because it progresses gradually, inflicting irreversible harm before any noticeable vision loss occurs. By the time glaucoma is identified through routine eye examinations, significant damage may have already occurred.
Hope is on the horizon, thanks to a collaborative effort between researchers at Northumbria University in the UK and Boğaziçi University in Turkey. They have successfully developed contact lenses designed to detect fluctuations in IOP. These lenses utilize the gathered information to diagnose glaucoma and have even undergone testing in individuals.
The contact lenses feature an electrically passive sensor embedded in a disposable, soft lens made from polydimethylsiloxane (PDMS). A wearable electronic readout system wirelessly collects, stores, and processes the data generated by the sensor. The processed data is then provided to an ophthalmologist for thorough evaluation.
This innovative approach holds promise in revolutionizing glaucoma diagnosis by enabling early intervention, potentially preventing irreversible vision loss in affected individuals.
Unlocking Ease in Eye Health
GlakoLens, a Novel Contact Lens, Simplifies Monitoring Intraocular Pressure for Accurate Diagnoses
Researchers have introduced GlakoLens, a novel contact lens designed to revolutionize the assessment of intraocular pressure (IOP) and enhance the accuracy of glaucoma diagnoses. Unlike conventional eye exams, GlakoLens facilitates effortless and prolonged IOP measurements, allowing for a more comprehensive understanding of eye health.
Hamdi Torun, the corresponding author of the study, emphasizes the significance of continuous monitoring, stating, "Intraocular pressure, or IOP, can vary greatly over a 24-hour period, making it essential to monitor patients at intervals or, ideally, continuously throughout the day for optimal insights into their eye health." Traditional methods, involving single-day clinic visits and techniques such as Goldmann applanation tonometry (GAT), can be misleading due to the natural fluctuations in IOP, requiring further investigation and hospitalization.
In contrast, GlakoLens offers a less invasive experience. Once inserted into the eye, patients can carry on with their daily activities while the lens records IOP measurements. After the 24-hour testing period, the collected data is sent to a doctor for analysis.
The researchers conducted initial tests on six healthy volunteers, instructing them to consume 1.5 liters of water to intentionally elevate IOP. The participants wore the GlakoLens on their left eye, while IOP in the right eye was measured separately for comparison. Results showed that the contact lens sensors effectively responded to the impact of water loading, with measurements aligning between the lens-wearing left eye and the device-free right eye.
Future experiments involving larger groups of healthy individuals will focus on assessing the sensor's accuracy and reliability. The researchers also aim to enhance the comfort and non-invasiveness of GlakoLens in subsequent iterations. This innovation promises a more patient-friendly approach to monitoring eye health and holds potential for transforming the landscape of glaucoma diagnosis.
Advancements in Glaucoma Detection: GlakoLens Stands Out Among Previous Innovations
While GlakoLens isn't the first of its kind, it distinguishes itself from previous glaucoma-detecting contact lenses. In February 2023, researchers at South Korea's Pohang University of Science and Technology (POSTECH) tested lenses that not only monitored glaucoma but also released IOP-reducing medication. However, their tests were limited to rabbits. Another approach, undertaken by a California-based startup in May, involved miLens, a ring placed in the eye to measure IOP physically. Despite promising results, the readings were only slightly different from those obtained through traditional methods.
What sets GlakoLens apart, according to the researchers, is its electrically passive sensor and soft contact lens. Unlike previous models using electrically active silicon chips, GlakoLens provides a thinner, more comfortable, and flexible lens that doesn't compromise vision.
In addition to glaucoma diagnosis, the researchers envision broader applications for their lenses. By measuring molecules like glucose and lactic acid in the eye, these lenses could potentially detect various health conditions.
Hamdi Torun, the study's lead, expressed optimism about the technology's potential: "We believe this technology has huge potential and could not only save the sight of patients in the early stages of glaucoma but also provide early diagnosis of other diseases in the future."
The findings were published in the journal Contact Lens and Anterior Eye, and the lenses are expected to be commercially available through the spin-off company GlakoLens, marking a significant stride in eye health technology.
Source: Northumbria University
symptoms of high eye pressure, what is normal eye pressure range, increased intraocular pressure, what is high eye pressure, glaucoma symptoms and treatment